The largest database of trusted experimental protocols

Dme f12 medium

Manufactured by Thermo Fisher Scientific
Sourced in United States

DME/F12 medium is a cell culture medium formulated for the growth and maintenance of a variety of cell types. It is a combination of Dulbecco's Modified Eagle's Medium (DMEM) and Ham's F-12 Nutrient Mixture. This medium provides a balanced set of nutrients, vitamins, and other components required for cell proliferation and survival in vitro.

Automatically generated - may contain errors

23 protocols using dme f12 medium

1

Hypoxia-Reoxygenation Model in HK-2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human proximal renal tubular epithelial cells (HK-2) were purchased from Procell Life Science&Technology Co., Ltd. (Wuhan, China) and cultured in DME/F12 medium (Gibco, United States) supplemented with 1% penicillin-streptomycin (Gibco, United States) and 10% fetal bovine serum (FBS, Gibco, United States) under 5% CO2 and 95% air atmosphere at 37°C. HK-2 cells were cultured in a medium containing CoCl2 (7791-13-1, Changsha Jingkang New Material Technology Co. LTD., China) without nutrients (serum-free, glucose-free) for 6 h. The medium was then replaced with DME/F12 with or without mefunidone for 12 h to induce the hypoxia/reoxygenation (H/R) model.
+ Open protocol
+ Expand
2

Clear Cell Renal Cell Carcinoma Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
This study enrolled subjects visiting the Department of Urology, Shanghai Ruijin Hospital between September 2018 and August 2021. Their clear cell renal cell carcinoma (ccRCC) tissues and adjacent normal tissues (ANT) were obtained during the surgical operation. The study conformed to the standards set by the Declaration of Helsinki was approved by the Ethics Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China (approval number: 2018‐381). All subjects gave written informed consent before their participation. Twenty‐eight pairs of samples including both ccRCC and ANT tissues were collected after surgery for the following experiments. ccRCC cell lines 786‐O and 769‐P and human proximal tubular epithelial cell line HK‐2 were provided by the National Collection of Authenticated Cell Cultures. 786‐O cells and 769‐P cells were immediately cultured in RPMI1640 medium (Gibco, Waltham, MA, USA) and HK‐2 cells were cultured in DME/F12 medium (Gibco) when the cell lines were obtained. All the culture media contained 10% fetal bovine serum (FBS), 100 U·mL−1 penicillin, and 100 μg·mL−1 streptomycin, and the cultured cells were kept in 95% humidity and 37 °C 5% CO2 incubator (Thermo, Waltham, MA, USA).
+ Open protocol
+ Expand
3

Isolation and Amplification of Fowl Adenovirus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver tissue samples were homogenized in phosphate-buffered saline (PBS), followed by filtration through a Millipore syringe filter with a pore size of 0.22 μm to produce an inoculum for viral isolation after undergoing 3 freeze-thaw cycles. Afterwards, the resulting supernatant was used to infect LMH cells grown as monolayer in DME/F-12 medium (Gibco) supplemented with 10% fetal bovine serum at 37°C under humidified conditions containing 5% CO2. The cells were observed daily to monitor any cytopathic effects. When 80% cytopathies were observed, both the supernatant and infected cells underwent 3 additional freeze-thaw cycles prior to collection. After 3 round of plaque purification procedure and exogenous pathogenic microorganism detection, the FAdV-positive supernatants were subsequently amplified on confluent monolayers of LMH cell. The purified strains were identified using PCR to rule out other viruses such as AIV, IBV, IBDV, NDV, FAdV-4, and CIAV.
+ Open protocol
+ Expand
4

Isolation and Culture of Bovine Mammary Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Firstly, fresh udder tissues were washed several times until the solution was pellucid and without milk. Secondly, the tissues were cut about 1 mm3 and were washed again with PBS. The smaller tissues were cultured in DME/F-12 medium (Gibco, Waltham, MA, USA) with 10% fetal calf serum (Gibco, Waltham, MA, USA), 5 μg/mL insulin, 100 U/mL penicillin and streptomycin (Gibco, Waltham, MA, USA), 10 ng/mL epidermal growth factor 1 (EGF-1, Gibco, Waltham, MA, USA) at 37 °C in a humidified atmosphere with 5% CO2. After about 1 week, the purified GMECs were received.
+ Open protocol
+ Expand
5

MCF10A Cell Culture and Drug Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF10A cells were grown as described20 (link) in DME:F12 medium (Gibco BRL, Grand Island, NY) supplemented with 10 μg ml−1 insulin, 0.1 μg ml−1 cholera toxin, 0.5 μg ml−1 HC, 5% heat-inactivated horse serum (Gibco BRL) and 10 ng ml−1 EGF. The cells were starved overnight in medium, and thereafter stimulated with EGF (10 ng ml−1) or DEX (100 nM). siRNA transfections used Oligofectamine (Invitrogen) and ON-Target SMART (Dharmacon, Lafayette, CO) oligonucleotides. Lapatinib (di-p-Toluenesulfonate salt) was purchased from LC Laboratories and formulated as a suspension in 0.5% hydroxypropyl methylcellulose and 0.1% Tween 80. The drug was administered via oral gavage as a single bolus dose. Mig6-specific short hairpin RNA particles were produced in 293FT cells using the corresponding plasmid.
+ Open protocol
+ Expand
6

Characterization of MCF10A Breast Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless indicated, cells were obtained from the American Type Tissue Culture Collection (ATCC). MCF10A cells were cultured in DME:F12 medium (Gibco BRL, Grand Island, NY, USA) supplemented with insulin (10 μg/ml), cholera toxin (0.1 μg/ml), hydrocortisone (0.5 μg/ml), heat-inactivated horse serum (5%; Gibco BRL) and EGF (10 ng/ml). The following antibodies were used: anti-DUSP1 (clone EPR18884 from Abcam), polyclonal anti-EGR1 (C-19; Santa Cruz), anti-FOS antibody (H-125; Santa Cruz), an antibody specific to the K27 acetylated form of histone 3 (from Abcam), a rabbit anti-GR polyclonal antibody (PA1-511A; Thermo Fisher Scientific) and an antibody to the N-terminus of RNA polymerase II (from Cell Signaling). Protein content was estimated using the BCA kit (from Sigma) and HBEGF was assayed using an ELISA kit (DuoSet, from R&D Systems, Minneapolis, MN, USA).
+ Open protocol
+ Expand
7

Breast Cancer Cell Line Culture and miR-20b Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human normal mammary epithelial cell line MCF-10A was cultured in DME/F12 medium (Gibco, USA) containing 5% horse serum, 10 μ g/ml insulin, 20 ng/ml EGF, 100 ng/ml choleratoxin, 0.5 μg/ml hydrocortisone, 100 IU/ml penicillin and 100 μg/ml streptomycin. Human breast cancer cell lines MCF-7 and T-47D were maintained in DMEM medium (Gibco) supplemented with 10% fetal bovine serum (FBS; Gibco), 100 IU/ml penicillin and 100 μg/ml streptomycin. Other human breast cancer cell lines ZR-75-30 and SK-BR-3 were cultured in RPMI-1640 medium (Gibco) supplemented with 10% FBS, 100 IU/ml penicillin and 100 μg/ml streptomycin in humidified 5% CO2 at 37°C. MiR-20b mimics, miR-20b inhibitor, antagomir-20b and their negative control were synthesized by Ribobio (RiboBio Co. Ltd., Guangzhou, China) [29 (link)].
The miR-20b gain-of-function study was performed using MiR-20b mimics (50 nM) and its negative control (50 nM) on the breast cancer cell lines. The loss-of-function study was performed with miR-20b inhibitor (100 nM) and its negative control (100 nM) on the cell lines. The cells were transfected using Lipofectamine RNAiMAX reagent (Invitrogen, USA) in accordance with the manufacturer’s instructions.
+ Open protocol
+ Expand
8

Tumorsphere Formation Assay for Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
This assay tests the ability of single cells to form tumorspheres, the in vitro surrogate of stem-like cell. Breast tumor cells (2 × 105 cells/well in 1.5 ml of medium) were distributed into ultralow attachment 6-well plates. Tumorspheres were grown in DME-F12 medium (Gibco), supplemented with penicillin/streptomycin, L-glutamine and B27 supplement (1x, #17504–044, Life technologies), fibroblast growth factor-2 (FGF-2) (20 ng/ml, #13256029, Gibco) and hEGF (20 ng/ml, #10605-HNAE, Gibco), and allowed to grow for 7 to 10 days, or until the majority of spheres reached a diameter of 60 μm. Tumorspheres were counted and then harvested for protein extraction or splitted for second generation of tumorspheres and next lysed for protein extraction [12 (link)].
+ Open protocol
+ Expand
9

MCF10A Cell Culture and RNA Metabolic Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF10A cells were cultured as described (32 (link)) in DME:F12 medium (Gibco BRL, Grand Island, NY, USA) supplemented with 10 μg ml−1 insulin, 0.1 μg ml−1 cholera toxin, 0.5 μg ml−1 hydrocortisone, 5% heat-inactivated horse serum (Biological Industries, Beit-Haemek, Israel) and 10 ng ml−1 EGF. For time course experiments, cells were starved overnight in medium without additives, and thereafter stimulated with EGF (10 ng ml−1) or dexamethasone (DEX; 100 nM). RNA metabolic labeling was performed in different concentrations of 4-thiouridine (4sU; Sigma), as recommended before (35 (link)). The labeling reagent was added to the medium (0.5 mM final concentration) and incubated with cells for 20 min. This was followed by 40 min of labeling (0.3 mM) and further incubations for 1, 2 or 4 h (0.2 mM). When treated with EGF, cells were concomitantly labeled with 4sU.
+ Open protocol
+ Expand
10

Porcine Trophectoderm Cell Line Response to GABA and H2O2

Check if the same lab product or an alternative is used in the 5 most similar protocols
The porcine trophectoderm cell line-2 (pTr-2) was kindly provided by Prof. Zhenlong Wu (China Agricultural University, Beijing, China). pTr-2 cells were cultured in DME/F12 medium (Gibco, New York, NY, USA) containing 10% (v/v) fetal bovine serum (Gibco, New York, NY, USA) and 0.1% (v/v) insulin (5 mg/mL, Solarbio, Beijing, China) at 37 °C and 5% CO2. Cells were treated with GABA (0, 25, 50, 100, or 200 μmol/L) for 24 h prior to stimulation with 0.6 mmol/L H2O2 for 2 h.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!